A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease
Clinical trial NCT02963350 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT02963350
- Sponsor
- BioMarin Pharmaceutical
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.